Apogee Therapeutics
About:
Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.
Website: https://apogeetherapeutics.com/
Top Investors: RA Capital Management, OrbiMed, Fidelity, Perceptive Advisors, RTW Investments
Description:
Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders. The company aims to advance novel therapies to address patients’ needs. Based in San Francisco, California, Apogee Therapeutics was founded in 2022.
Total Funding Amount:
$652M
Estimated Revenue Range:
$1B to $10B
Headquarters Location:
San Francisco, California, United States
Founded Date:
2022-01-01
Founders:
Nimish Shah
Number of Employees:
101-250
Last Funding Date:
2024-03-07
IPO Status:
Public
© 2025 bioDAO.ai